InvestorsHub Logo
Followers 813
Posts 71326
Boards Moderated 2
Alias Born 01/30/2003

Re: Pennybuster post# 14387

Tuesday, 03/15/2016 8:57:09 AM

Tuesday, March 15, 2016 8:57:09 AM

Post# of 17485
$OREX Up BIG This Morning On News!!





Orexigen Therapeutics to Host Conference Call at 8:30 a.m. Eastern Time Today to Discuss Acquisition of U.S. Rights to Contra...
Print
Alert
Orexigen Therapeutics, Inc. (MM) (NASDAQ:OREX)
Intraday Stock Chart
Today : Tuesday 15 March 2016

Click Here for more Orexigen Therapeutics, Inc. (MM) Charts.
SAN DIEGO, March 15, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will host a conference call this afternoon to discuss the strategic acquisition of all U.S. rights to Contrave® and the Mysimba® commercialization and distribution agreement with Valeant Pharmaceuticals International, Inc. for Central and Eastern Europe.

The call will be held today at 8:30 a.m. ET / 5:30 a.m. PT and may be accessed by phone by calling (888) 771-4371 (domestic) or (847) 585-4405 (international), participant code 42093506. The webcast can be accessed live on the Investors section of the Orexigen web site at http://www.orexigen.com, and will be archived for 14 days following the call.

Orexigen Contact:

Media Contact:

McDavid Stilwell

Julie Normart

VP, Corporate Communications and Business Development

BrewLife

(858) 875-8629

(415) 946-1087

mstilwell@orexigen.com

jnormart@brewlife.com



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-host-conference-call-at-830-am-eastern-time-today-to-discuss-acquisition-of-us-rights-to-contrave-naltrexone-hcl--bupropion-hcl-extended-release-and-central-and-eastern-europe-distribution-agreeme-300236043.html

SOURCE Orexigen Therapeutics, Inc.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.